Compare Abbott Laboratories (ABT) vs iShares 7-10 Year Treasury Bond ETF (IEF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs iShares 7-10 Year Treasury Bond ETF — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while iShares 7-10 Year Treasury Bond ETF trades at $93.48. The key difference: Abbott Laboratories pays a 2.63% dividend while iShares 7-10 Year Treasury Bond ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ABT | IEF | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $97.99 |
52-Week Low | $82.57 | $93.11 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
IEF, a US stock, trades at $93.7, down 0.45% over 24 hours, with a bearish technical signal driven by moving averages. Recent corporate actions include dividend payments scheduled for mid-2026. The stock lacks key valuation and profitability ratios in the provided data, limiting fundamental assessment. News highlights bond market dynamics and Federal Reserve policy uncertainty influencing sentiment.
The outlook for IEF is cautious due to bearish technical indicators and macroeconomic headwinds like potential rate hikes. Investment opportunities may arise from dividend distributions, but risks include market volatility and Fed policy shifts. Investors should weigh technical weakness against income potential in a fluctuating interest rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →
